Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

  1. Muñoz Builes, M.
  2. Vela Cuenca, M.
  3. Fuster Soler, J.L.
  4. Astigarraga, I.
  5. Pascual Martínez, A.
  6. Vagace Valero, J.M.
  7. Tong, H.Y.
  8. Valentín Quiroga, J.
  9. Fernández Casanova, L.
  10. Escudero López, A.
  11. Sisinni, L.
  12. Blanquer, M.
  13. Mirones Aguilar, I.
  14. González Martínez, B.
  15. Borobia, A.M.
  16. Pérez-Martínez, A.
Revista:
BMJ Open

ISSN: 2044-6055

Ano de publicación: 2020

Volume: 10

Número: 1

Tipo: Artigo

DOI: 10.1136/BMJOPEN-2019-029642 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus